Growth Direct

The Growth Direct System by Rapid Micro Biosystems is an automated microbial detection platform designed for pharmaceutical and biotech quality control labs operating under FDA and EMEA regulations.

Reviewed by 7wData
API Available

On this page

Publisher review

The Growth Direct System by Rapid Micro Biosystems is an automated microbial detection platform designed for pharmaceutical and biotech quality control labs operating under FDA and EMEA regulations. It replaces manual colony counting with touch-free incubation and imaging, specifically targeting environmental monitoring and bioburden testing applications. The system detects microbial growth through natural auto-fluorescence without reagents, making it non-destructive for downstream analysis.

Pharmaceutical manufacturers with high-volume testing needs benefit most from its ability to accelerate results while maintaining compliance with 21 CFR Part 11 electronic record requirements. Key capabilities include automated plate reading every 90 minutes, detecting growth as early as 6 hours, and delivering final results in half the time of traditional methods (7 vs 14 days for sterility tests). The system integrates directly with LIMS, providing audit trails and eliminating manual data transcription errors.

It handles up to 2,000 tests per day without additional lab staff, with units deployable near production lines to reduce sample transit time. Compared to traditional manual methods and competing rapid microbiological methods like Milliflex Quantum and BioVigilant, Growth Direct uniquely combines non-destructive testing with full compendial compliance. However, the system requires significant upfront validation and lacks published pricing transparency.

While it reduces labor by 80% for colony counting, labs still must prepare samples manually. The technology also cannot identify microbial species, requiring follow-up tests for speciation.

Get the AI & data signal, daily.

335k+ subscribers read this every morning. One email, both newsletters. Unsubscribe anytime.

How it works

  1. Automated colony detection

    Uses high-resolution imaging every 90 minutes to detect microbial growth via natural auto-fluorescence, identifying colonies in as little as 6 hours

  2. Non-destructive testing

    Preserves samples for downstream analysis since it detects growth without chemical reagents or destructive processes

  3. 21 CFR Part 11 compliance

    Maintains fully electronic records with audit trails and secure data integrity for regulated environments

  4. LIMS integration

    Automatically transfers colony counts and images to laboratory information systems, eliminating manual data entry errors

  5. High-volume processing

    Handles up to 2,000 tests daily without additional staff, scaling for production increases

  6. Proximity deployment

    Units can be installed near manufacturing lines to reduce sample transit time and contamination risk

  7. Rapid sterility testing

    Cuts 14-day compendial sterility test timelines in half while maintaining regulatory acceptance

Strengths and trade-offs

Strengths

  • Reduces time-to-result by 50% compared to manual methods, with sterility tests completing in 7 days instead of 14.
  • Eliminates 80% of manual labor for colony counting through fully automated incubation and enumeration.
  • Maintains compliance with strict regulatory requirements including FDA 21 CFR Part 11 for electronic records.
  • Enables non-destructive testing by detecting natural auto-fluorescence without chemical reagents.

Trade-offs

  • Requires extensive validation documentation for regulatory approval despite being compendial.
  • Sample preparation remains manual even though incubation and reading are automated.
  • Cannot speciate microorganisms, requiring additional testing for identification.
  • No transparent published pricing structure for budgeting and cost comparisons.

Pricing context

Enterprise pricing model not publicly disclosed; requires direct consultation for capital equipment and consumables costs

Getting started with Growth Direct

  1. Request consultation

    Contact Rapid Micro Biosystems to schedule a product demonstration and discuss implementation requirements for your lab environment.

  2. Prepare lab space

    Allocate clean bench space near production lines if deploying proximity units, ensuring proper power and network connectivity for the system.

  3. Validate system

    Work with quality teams to complete required validation protocols for regulatory compliance before putting the system into production use.

  4. Load samples

    Manually prepare and position test plates into the Growth Direct System according to your standard operating procedures.

  5. Monitor results

    Review automated colony counts and images in the system interface or integrated LIMS as tests complete, typically within 7 days for sterility.

Frequently Asked Questions

What is Growth Direct and how does it work?

Growth Direct is an automated microbial detection system for pharmaceutical labs. It replaces manual colony counting with touch-free incubation and high-resolution imaging every 90 minutes, detecting growth via natural auto-fluorescence without reagents. Results appear in half the time of traditional methods while maintaining sample integrity.

How does Growth Direct compare to manual microbial testing?

Growth Direct reduces testing time by 50%, delivering sterility results in 7 days versus 14. It automates 80% of colony counting labor while maintaining compliance. Unlike manual methods, it provides continuous monitoring with imaging every 90 minutes and eliminates transcription errors through direct LIMS integration.

Is Growth Direct compliant with pharmaceutical regulations?

Yes, Growth Direct meets FDA 21 CFR Part 11 requirements for electronic records and audit trails. It's designed for regulated environments, maintaining data integrity for environmental monitoring and bioburden testing. However, labs must complete extensive validation documentation before implementation to ensure regulatory acceptance.

What are the limitations of Growth Direct?

Growth Direct requires manual sample preparation and cannot identify microbial species, necessitating follow-up tests. Implementation demands significant validation work. Pricing isn't publicly available, requiring direct consultation. While automating incubation and reading, some manual steps remain in the testing workflow.

How quickly can Growth Direct detect microbial growth?

Growth Direct identifies microbial colonies in as little as 6 hours through continuous monitoring. The system captures high-resolution images every 90 minutes during incubation. This rapid detection cuts standard 14-day sterility test timelines in half while preserving samples for potential downstream analysis.

Who benefits most from using Growth Direct?

Pharmaceutical and biotech quality control labs with high-volume testing needs gain the most benefit. The system handles up to 2,000 daily tests without added staff, ideal for manufacturers needing faster results while maintaining compliance. Units can deploy near production lines to minimize sample transit time.

Alternatives

How Growth Direct compares

Direct head-to-head against 2 competitors. Picked by 7wData.

This tool

Growth Direct

Pricing
Enterprise pricing model not publicly disclosed; requires direct consultation for capital equipment and consumables costs
Target
The Growth Direct System by Rapid Micro Biosystems is an automated microbial detection platform designed for pharmaceutical and biotech quality control labs operating under FDA
Strength
Reduces time-to-result by 50% compared to manual methods, with sterility tests completing in 7 days instead of 14.
Watch for
Requires extensive validation documentation for regulatory approval despite being compendial.

bioMérieux S.A.

Pricing
Custom/Contact sales
Target
Microbial detection in healthcare
Deployment
On-premises
Strength
Global leader in microbiological diagnostics
Watch for
Complex setup and integration

User reviews

No user reviews yet. Be the first to write one.

Sources

Reporting on this tool draws on these publicly available sources.

  1. cleanroomtechnology.com
  2. finance.yahoo.com
  3. www.rapidmicrobio.com
  4. www.rapidmicrobio.com